ESCRT-II Complex Plays A Crucial Role in Intracellular Protein Delivery

Target Name: ESCRT-II complex

NCBI ID: P26182

ESCRT-II complex

Other Name(s): Endosomal sorting complex required for transport II

ESCRT-II Complex Plays A Crucial Role in Intracellular Protein Delivery

Endosomal sorting complex required for transport (ESCRT-II) is a protein that plays a crucial role in the process of intracellular protein delivery. It is a protein complex that is involved in the sorting of various proteins into the endosomal system for transport to various cellular compartments. ESCRT-II complex is composed of several proteins that work together to ensure the efficient delivery of proteins into the endosomal system.

The endosomal system is a specialized structure that is responsible for the delivery of proteins to various cellular compartments. It is composed of several vesicles that are derived from the endoplasmic reticulum. The endosomal system is involved in the delivery of proteins to the cytosol, the mitochondria, the endoplasmic reticulum, and other cellular compartments. ESCRT-II complex is a key protein that is involved in the sorting of proteins into the endosomal system.

ESCRT-II complex is a protein complex that is composed of several subunits that work together to ensure the efficient delivery of proteins into the endosomal system. It is composed of the protein ESCRT-II, which is a key subunit that is involved in the sorting of proteins into the endosomal system. Other subunits of ESCRT-II complex include CTBP, p110, and p620.

CTBP (Cullin-3-like transmembrane protein) is a protein that is involved in the binding of ESCRT-II complex to the endosomal system. It is composed of several domains, including an N-terminal transmembrane domain, a coiled-coil domain, and a C-terminal protein-coding domain. CTBP plays a crucial role in the binding of ESCRT-II complex to the endosomal system by interacting with the protein p110.

p110 is a protein that is involved in the binding of ESCRT-II complex to the endosomal system. It is composed of several domains, including an N-terminal transmembrane domain, a coiled-coil domain, and a C-terminal protein-coding domain. p110 plays a crucial role in the binding of ESCRT-II complex to the endosomal system by interacting with the protein CTBP.

p620 is a protein that is involved in the binding of ESCRT-II complex to the endosomal system. It is composed of several domains, including an N-terminal transmembrane domain, a coiled-coil domain, and a C-terminal protein-coding domain. p620 plays a crucial role in the binding of ESCRT-II complex to the endosomal system by interacting with the protein CTBP.

ESCRT-II complex is involved in the efficient delivery of proteins into the endosomal system by ensuring that the proteins it sorts are properly targeted for transport. This is achieved through the interaction of ESCRT-II complex with various proteins that are involved in the endosomal system. CTBP, p110, and p620 are all involved in the interaction of ESCRT-II complex with the endosomal system.

CTBP is involved in the interaction of ESCRT-II complex with the endosomal system by interacting with the protein p110. This interaction between CTBP and p110 is critical for the efficient delivery of proteins into the endosomal system. P110 is involved in the interaction of ESCRT-II complex with the endosomal system by interacting with the protein CTBP. This interaction between

Protein Name: ESCRT-II Complex

The "ESCRT-II complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ESCRT-II complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets